DaVita (BSP:DVAI34) Cyclically Adjusted Revenue per Share: R$665.01 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BSP:DVAI34 DaVita Inc BSP:DVAI34
17 GF Score
Price R$929.47
GF Value R$1,015.31
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is DaVita Cyclically Adjusted Revenue per Share?

DaVita BSP:DVAI34 -1.32% 17 Cyclically Adjusted Revenue per Share is R$665.01 as of Jun. 2026. GuruFocus rates BSP:DVAI34 with a GF Score™ of 17/100 and a GF Value™ of R$1,015.31 (Fairly Valued). The stock has 6 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

DaVita's adjusted revenue per share for the three months ended in Jun. 2026 was R$275.547. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is R$665.01 for the trailing ten years ended in Jun. 2026.

During the past 12 months, DaVita's average Cyclically Adjusted Revenue Growth Rate was 15.60% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 11.40% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 12.90% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was 12.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of DaVita was 24.40% per year. The lowest was 9.30% per year. And the median was 14.30% per year.

As of today (2026-08-12), DaVita's current stock price is R$929.47. DaVita's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 was R$665.01. DaVita's Cyclically Adjusted PS Ratio of today is 1.40.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of DaVita was 1.95. The lowest was 0.78. And the median was 1.36.


DaVita  (BSP:DVAI34) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

DaVita's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=929.47/665.01
=1.40

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of DaVita was 1.95. The lowest was 0.78. And the median was 1.36.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


DaVita Cyclically Adjusted Revenue per Share Related Terms


DaVita Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for DaVita's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

DaVita Cyclically Adjusted Revenue per Share Chart

DaVita Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 425.28 439.19 485.64 652.79 683.42

DaVita Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 602.03 600.59 683.42 647.09 665.01

BSP:DVAI34 vs EHC, THC, ENSG: Cyclically Adjusted Revenue per Share Comparison

For the Medical Care Facilities subindustry, DaVita's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


DaVita Cyclically Adjusted PS Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, DaVita's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where DaVita's Cyclically Adjusted PS Ratio falls into.


BSP:DVAI34
17GF Score
DaVita Inc BSP:DVAI34
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

DaVita Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, DaVita's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=275.547/333.9520*333.9520
=275.547

Current CPI (Jun. 2026) = 333.9520.

DaVita Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 58.641 241.428 81.114
201612 46.019 241.432 63.654
201703 42.140 243.801 57.722
201706 45.856 244.955 62.516
201709 45.252 246.819 61.227
201712 49.577 246.524 67.159
201803 51.384 249.554 68.762
201806 62.529 251.989 82.867
201809 69.943 252.439 92.528
201812 65.833 251.233 87.509
201903 63.169 254.202 82.987
201906 65.711 256.143 85.672
201909 79.072 256.759 102.845
201912 91.278 256.974 118.621
202003 109.404 258.115 141.548
202006 120.438 257.797 156.016
202009 127.386 260.280 163.442
202012 129.175 260.474 165.614
202103 139.576 264.877 175.975
202106 131.622 271.696 161.782
202109 141.221 274.310 171.926
202112 158.863 278.802 190.288
202203 139.511 287.504 162.050
202206 151.100 296.311 170.295
202209 165.787 296.808 186.534
202212 166.530 296.797 187.377
202303 161.789 301.836 179.004
202306 155.890 305.109 170.627
202309 163.921 307.789 177.855
202312 166.135 306.746 180.870
202403 168.871 312.332 180.560
202406 192.962 314.175 205.109
202409 210.655 315.301 223.116
202412 239.781 315.605 253.720
202503 228.378 319.799 238.485
202506 242.266 322.561 250.821
202509 248.650 324.800 255.656
202512 277.312 324.054 285.782
202603 259.339 330.213 262.275
202606 275.547 333.952 275.547

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of R$665.01 mean?
DaVita (BSP:DVAI34) has a Cyclically Adjusted Revenue per Share of R$665.01 as of Jun. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on DaVita and its competitors.
Is DaVita's Cyclically Adjusted Revenue per Share too high?
DaVita's current Cyclically Adjusted Revenue per Share is R$665.01. Overall, DaVita has a GF Score™ of 17/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does DaVita's Cyclically Adjusted Revenue per Share compare to EHC and THC?
DaVita's Cyclically Adjusted Revenue per Share of R$665.01 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Healthcare Providers & Services company?
A good Cyclically Adjusted Revenue per Share depends on the Healthcare Providers & Services industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on DaVita and its competitors. DaVita's current Cyclically Adjusted Revenue per Share is R$665.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DaVita stock overvalued right now?
Based on GuruFocus' analysis, DaVita (BSP:DVAI34) is currently considered Fairly Valued. The stock's GF Value™ is R$1,015.31, compared to a current price of R$929.47 — trading 8.5% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is R$665.01. DaVita's overall GF Score™ is 17/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For DaVita (BSP:DVAI34), the current Cyclically Adjusted Revenue per Share is R$665.01 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is DaVita (BSP:DVAI34) Overvalued in 2026?

Based on GuruFocus' analysis, DaVita stock appears to be undervalued. The current stock price of R$929.47 is trading 8.5% below its estimated GF Value™ of R$1,015.31. GuruFocus considers DaVita to be Fairly Valued.

Key valuation signals for BSP:DVAI34:

  • Cyclically Adjusted Revenue per Share: R$665.01
  • GF Value™: R$1,015.31 vs. price of R$929.47 (8.5% below fair value)
  • GF Score™: 17/100 with 6 warning signs

No single metric tells the full story. See the BSP:DVAI34 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


DaVita Business Description

Address 2000 16th Street, Denver, CO, USA, 80202
DaVita is one of the largest providers of dialysis services in the United States, boasting a market share of about 35%. The firm operates over 3,200 facilities worldwide, mostly in the US, and treats about 300,000 patients annually. Government payers dominate US dialysis reimbursement. DaVita receives about two-thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business.
17GF Score

Get the complete analysis for BSP:DVAI34

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$929.47
Price
R$1,015.31
GF Value